Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Catalent Inc (NY: CTLT )

56.05 -0.59 (-1.04%)
Official Closing Price Updated: 7:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,012,269
Open 55.06
Bid (Size) 51.68 (1)
Ask (Size) 58.38 (1)
Prev. Close 56.64
Today's Range 55.06 - 57.52
52wk Range 40.69 - 115.33
Shares Outstanding 170,341,553
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Analyst Ratings for Catalent
 
Via Benzinga
Barclays Maintains Overweight Rating for Catalent: Here's What You Need To Know
 
Via Benzinga

Performance

YTD
+23.32%
+23.32%
1 Month
+20.67%
+20.67%
3 Month
+32.04%
+32.04%
6 Month
-49.30%
-49.30%
1 Year
-45.61%
-45.61%

More News

Read More
Catalent, Inc. Announces Second Quarter Fiscal Year 2023 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
Catalent Appoints Ricardo Zayas as North American Biologics Operations Leader
From Catalent, Inc.
Via Business Wire
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
Via Benzinga
Why Shares of Catalent Fell 36% This Week
Via The Motley Fool
Sarepta and Catalent Expand Strategic Manufacturing Partnership With Commercial Supply Agreement for Duchenne Muscular Dystrophy Gene Therapy Candidate
From Catalent, Inc.
Via Business Wire
Catalent, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Catalent, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
Via Benzinga
Catalent Announces Changes to its Board of Directors
From Catalent, Inc.
Via Business Wire
Can Stocks Buck The Rising Odds Of A Recession?
Via Talk Markets
Battered FTX's CEO Sam Bankman-Fried Arrested, Elon Musk's SpaceX Mammoth Valuation Of $140B, China Weighs Over $143B In Semiconductor Push: Top Stories Tuesday, Dec. 13
Via Benzinga
After US Launch Bottlenecks, Novo Nordisk Pushes European Rollout For Wegovy In 2023
Via Benzinga
After a $100 Haircut, is Catalent an Oversold Pharma Play?
Via MarketBeat
Catalent, Inc. to Present at the Stephens Annual Investment Conference
From Catalent, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022
Via Benzinga
Exelixis and Catalent Enter into New License Agreement for Three Antibody-Drug Conjugate Programs with the Potential to Accelerate Exelixis’ Biologics Pipeline
From Exelixis, Inc.
Via Business Wire
Where Catalent Stands With Analysts
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
Via Benzinga
Analyst Ratings for Catalent
Via Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Via Benzinga
Why Catalent Stock Plummeted by Nearly 25% Today
Via The Motley Fool
Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Unity Biotechnology (UBX) Stock Pops on Positive Study Data
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.